Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis

被引:0
|
作者
Hu, Hui Zheng [1 ]
Wu, Li Bo [1 ]
Liu, Qian [1 ]
Wu, Bin Yan [1 ]
Wang, Yu [2 ]
Wang, Rui Ying [2 ]
机构
[1] Nucl Ind 215 Hosp Shaanxi Prov, Dept Clin Lab, Xianyang 712000, Shaanxi, Peoples R China
[2] Nucl Ind 215 Hosp Shaanxi Prov, Dept Clin Cardiol, Xianyang 712000, Shaanxi, Peoples R China
来源
NEW MICROBIOLOGICA | 2024年 / 47卷 / 01期
关键词
COVID-19; CAPA; infections; risk factors; diagnosis; GALACTOMANNAN;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The objective of this study was to investigate the risk factors and diagnosis measure of COVID-19-associated pulmonary aspergillosis (CAPA). This study included 201 COVID-19 patients from December 1, 2022, to January 31, 2023; 7 (3.5%) were diagnosed with CAPA. The main risk factors were age, MV, ICU admission and COPD, and the presence of comorbidities such as ARDS and hypoproteinemia in COVID-19 patients, more susceptible to Aspergillus infection. In addition to specimen culture in the lower respiratory tract, the 1,3-beta-D-glucan antigen test can serve as an important screening indicator for early CAPA diagnosis in non-granulocytopenia patients.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 50 条
  • [41] COVID-19 and tuberculosis co-infection: a neglected paradigm
    Bandyopadhyay, Arkapal
    Palepu, Sarika
    Bandyopadhyay, Krishna
    Handu, Shailendra
    MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (03) : 518 - 522
  • [42] Leptospirosis and COVID-19 co-infection case in Bangladesh
    Amin, Mohammad Ashraful
    Nahin, Sabrina
    Bonna, Atia Sharmin
    Rozars, Md Faisal Kabir
    Hawlader, Mohammad Delwer Hossain
    HELIYON, 2022, 8 (11)
  • [43] Co-Infection in COVID-19 Pneumonia: Discussion Continues
    Strelkova, Daria
    Rachina, Svetlana
    Klimenko, Alexey
    Yatsyshina, Svetlana
    Cheboksarov, Dmitry
    Cherkasova, Tatiana
    Ramazanov, Natig
    Ananicheva, Nataliia
    INFECTION AND CHEMOTHERAPY, 2022, 54 (04): : 792 - 796
  • [44] Co-infection of COVID-19 and pulmonary tuberculosis: a case report on lung and liver damage
    Bereda, Gudisa
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (04): : 2346 - 2348
  • [45] Comment on: Incidence and co-infection with COVID-19 of dengue during the COVID-19 pandemic
    Daungsupawong, Hinpetch
    Wiwanitkit, Viroj
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2025, 124 (01) : 95 - 95
  • [46] Optimal control analysis of a COVID-19 and Tuberculosis (TB) co-infection model with an imperfect vaccine for COVID-19
    Diabaté A.B.
    Sangaré B.
    Koutou O.
    SeMA Journal, 2024, 81 (3) : 429 - 456
  • [47] Mortality and Clinical Outcomes of Aspergillus and COVID-19 Co-infection: A Retrospective Analysis
    Cazzaniga, Juliana
    Koutras, Nicole
    Patel, Premalkumar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [48] Mathematical analysis of COVID-19 and TB co-infection dynamics with optimal control
    Jain, Kshama
    Bhattacharjee, Anuradha
    Krishnamurhty, Srikumar
    MODELING EARTH SYSTEMS AND ENVIRONMENT, 2025, 11 (01)
  • [49] Modelling and Analysis on Co-infection of COVID-19 and TB and Optimal Control Strategy
    Xunyang Wang
    Fan Chen
    Di Wu
    International Journal of Applied and Computational Mathematics, 2025, 11 (3)
  • [50] Secondary Infection and Co-infection in COVID-19 Patients Receiving Tocilizumab
    Erdogan, Cagla
    Kilinc, Metin
    Sahin, Beyza
    Sungurtekin, Huelya
    TURKISH JOURNAL OF INTENSIVE CARE-TURK YOGUN BAKIM DERGISI, 2024, 22 (02): : 110 - 115